Biopharmaceuticals are regarded as one of the most exciting areas of modern medicines. In contrast to chemically synthesized pharmaceuticals, biopharmaceuticals are “grown” and “harvested” though a process of fermentation and subsequent purification steps. Through the formulation, additional properties may be achieved to improve delivery and bioavailability. Many biopharmaceuticals are being used in clinical practice to treat a variety of medical conditions, including diabetes, leukemia and hemophilia.
"Biopartners is uncompromising in its development of Biopharmaceuticals that are both safe and efficient."

Biopartners' advanced product portfolio consists of first-generation biopharmeceuticals with innovative-formulations or novel delivery systems.

Click here to hear current CEO Conrad Savoy and Jean-Nöel Treilles talking about the company, and products Interferon Beta and Sustained-release Human Growth Hormone, in a short video


Product Pipeline